Trichosporon pullulans infection in 2 patients with chronic granulomatous disease:: An emerging pathogen and review of the literature

被引:25
作者
Moylett, EH
Chinen, J
Shearer, WT
机构
[1] Texas Childrens Hosp, Sect Allergy & Immunol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Sect Allergol & Immunol, Houston, TX 77030 USA
关键词
chronic granulomatous disease; Trichosporon pullulans; emerging pathogen;
D O I
10.1067/mai.2003.1522
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Chronic granulomatous disease is a genetically determined primary immunodeficiency disease in which phagocytic cells are unable to kill certain bacteria and fungi after ingestion. Manifestations include recurrent pyogenic infections caused by catalase-positive microbes. Trichosporoa species are emerging as opportunistic agents that cause systemic disease in immunocompromised patients. Typically disease has been described in association with T beigelli in patients with secondary immunodeficiency, such as underlying malignancy. Objective: The objective was to report the first 2 cases of T pullulans infection in 2 male children with chronic granulomatous disease. Methods: The records of the 2 patients were reviewed. In addition, all cases of T pullulans infection reported in the English language literature are presented. Results: This report brings to 7 the total number of cases of T pullulans reported and the first in patients with chronic granulomatous disease, one with invasive pneumonia and the other with an infected paronychium and localized cellulitis. In the 5 additional cases malignancy was the principal risk factor. Conclusion: T pullulans has rarely been reported as a fungal pathogen. The most prominent risk factor for the development of trichosporonosis is immunocompromise most notably with neutropenia. Abnormally functioning neutrophils, such as with chronic granulomatous disease, may also predispose individuals to this opportunistic pathogen. (J Allergy Clin Immunol 2003;111:1370-4.).
引用
收藏
页码:1370 / 1374
页数:5
相关论文
共 21 条
  • [1] EMERGING FUNGAL PATHOGENS
    ANAISSIE, EJ
    BODEY, GP
    RINALDI, MG
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (04) : 323 - 330
  • [2] Trichosporon beigelii:: a life-threatening pathogen in immunocompromised hosts
    Erer, B
    Galimberti, M
    Lucarelli, G
    Giardini, C
    Polchi, P
    Baronciani, D
    Gaziev, D
    Angelucci, E
    Izzi, G
    [J]. BONE MARROW TRANSPLANTATION, 2000, 25 (07) : 745 - 749
  • [3] Yeast identification in the clinical microbiology accepted 15 August 2000 laboratory: phenotypical methods
    Freydiere, AM
    Guinet, R
    Boiron, P
    [J]. MEDICAL MYCOLOGY, 2001, 39 (01) : 9 - 33
  • [4] Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate
    Goodman, D
    Pamer, E
    Jakubowski, A
    Morris, C
    Sepkowitz, K
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (03) : E35 - E36
  • [5] Onychomycosis and Trichosporon beigelii in Korea
    Han, MH
    Choi, JH
    Sung, KJ
    Moon, KC
    Koh, JK
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2000, 39 (04) : 266 - 269
  • [6] INFECTION WITH TRICHOSPORON-PULLULANS
    HUGHES, CE
    SERSTOCK, D
    WILSON, BD
    PAYNE, W
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (05) : 772 - 773
  • [7] Hematogenous trichosporonosis in cancer patients:: report of 12 cases including 5 during prophylaxis with itraconazol
    Krcmery, V
    Mateicka, F
    Kunová, A
    Spánik, S
    Gyarfás, J
    Sycová, Z
    Trupl, J
    [J]. SUPPORTIVE CARE IN CANCER, 1999, 7 (01) : 39 - 43
  • [8] KREMERY V, 2002, J MED MICROBIOL, V51, P110
  • [9] REPORT OF CATHETER-ASSOCIATED TRICHOSPORON PULLULANS BREAKTHROUGH FUNGEMIA IN A CANCER-PATIENT
    KUNOVA, A
    SORKOVSKA, D
    SUFLIARSKY, J
    HELPIENSKA, L
    KRCMERY, V
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (08) : 729 - 730
  • [10] Fatal Trichosporon pullulans breakthrough fungemia in cancer patients: Report of three patients who failed on prophylaxis with itraconazole
    Kunova, A
    Godal, J
    Sufliarsky, J
    Spanik, S
    Kollar, T
    Krcmery, V
    [J]. INFECTION, 1996, 24 (03) : 273 - 274